Literature DB >> 20010919

Ten-day sequential therapy of Helicobacter pylori infection in Thailand.

Nathavut Sirimontaporn1, Duangporn Thong-Ngam, Somying Tumwasorn, Varocha Mahachai.   

Abstract

OBJECTIVES: Antimicrobial resistance has decreased eradication rates of Helicobacter pylori worldwide. The objective of this study was to determine whether a sequential therapy regimen is effective in eradicating H. pylori in adults with nonulcer dyspepsia or peptic ulcer disease in Thailand.
METHODS: A total of 115 patients with dyspepsia or peptic ulcer were enrolled in the study. (14)C-urea breath test, upper endoscopy, rapid urease test, bacterial culture, and antibiotic resistance assessment were conducted during the course of the treatment. In all, 115 patients underwent a 10-day sequential regimen, which consisted of lansoprazole (30 mg) plus amoxicillin (1 g) twice a day for 5 days, then lansoprazole (30 mg) with metronidazole (500 mg) twice a day, and clarithromycin (1,000 mg) once a day for another 5 consecutive days. Successful eradication was evaluated by negative urea breath test at least 4 weeks after stopping treatment.
RESULTS: Successful eradication was achieved in 106 of 115 patients (95%). All patients completed the treatment, without any dropouts. Mild adverse effects included headache and palpitations. The prevalence rate of clarithromycin-resistant H. pylori was found to be 6.1%.
CONCLUSIONS: The 10-day sequential treatment for H. pylori is well tolerated and provides a high eradication rate. This regimen can overcome the emergence of antibiotic resistance and may have a role as a first-line treatment for H. pylori infection in Thailand.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010919     DOI: 10.1038/ajg.2009.708

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.

Authors:  Hyun Jeong Lee; Jin Il Kim; Jin Soo Lee; Eun Jung Jun; Jung-Hwan Oh; Dae Young Cheung; Woo Chul Chung; Byung-Wook Kim; Sung Soo Kim
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

2.  Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

Authors:  Ayse Kefeli; Sebahat Basyigit; Abdullah Ozgur Yeniova; Tarık Tayfur Kefeli; Muzaffer Aslan; Ozlem Tanas
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

3.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.

Authors:  Hassan Seddik; Samir Ahid; Tarek El Adioui; Fatim-Zohra El Hamdi; Mohammed Hassar; Redouane Abouqal; Yahia Cherrah; Ahmed Benkirane
Journal:  Eur J Clin Pharmacol       Date:  2013-05-22       Impact factor: 2.953

4.  Update on triple therapy for eradication of Helicobacter pylori: current status of the art.

Authors:  Riccardo Urgesi; Rossella Cianci; Maria Elena Riccioni
Journal:  Clin Exp Gastroenterol       Date:  2012-09-17

5.  Newer agents for Helicobacter pylori eradication.

Authors:  Giulia Fiorini; Angelo Zullo; Luigi Gatta; Valentina Castelli; Chiara Ricci; Francesca Cassol; Dino Vaira
Journal:  Clin Exp Gastroenterol       Date:  2012-06-18

6.  Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Jyh-Ming Liou; Hsiu-Hsi Chen; Ming-Shiang Wu; David Y Graham
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

Review 7.  Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.

Authors:  Ju Yup Lee; Kyung Sik Park
Journal:  Gastroenterol Res Pract       Date:  2016-12-13       Impact factor: 2.260

8.  The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012.

Authors:  Chao-Hung Kuo; Fu-Chen Kuo; Huang-Ming Hu; Chung-Jung Liu; Sophie S W Wang; Yen-Hsu Chen; Ming-Chia Hsieh; Ming-Feng Hou; Deng-Chyang Wu
Journal:  Gastroenterol Res Pract       Date:  2012-06-27       Impact factor: 2.260

Review 9.  Quinolone-containing therapies in the eradication of Helicobacter pylori.

Authors:  Seng-Kee Chuah; Wei-Chen Tai; Chen-Hsiang Lee; Chih-Ming Liang; Tsung-Hui Hu
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

10.  Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.

Authors:  Chung-Chuan Chan; Nai-Hsuan Chien; Chia-Long Lee; Yi-Chen Yang; Chih-Sheng Hung; Tien-Chien Tu; Chi-Hwa Wu
Journal:  BMC Gastroenterol       Date:  2015-12-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.